Trade Akoya Biosciences, Inc. - AKYA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.26 |
| Open | 1.19 |
| 1-Year Change | -68.52% |
| Day's Range | 1.19 - 1.28 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 1.26 | 0.01 | 0.80% | 1.25 | 1.29 | 1.21 |
| Apr 23, 2025 | 1.24 | 0.03 | 2.48% | 1.21 | 1.29 | 1.19 |
| Apr 22, 2025 | 1.14 | 0.05 | 4.59% | 1.09 | 1.17 | 1.09 |
| Apr 21, 2025 | 1.09 | 0.06 | 5.83% | 1.03 | 1.10 | 1.00 |
| Apr 17, 2025 | 1.06 | -0.07 | -6.19% | 1.13 | 1.16 | 1.04 |
| Apr 16, 2025 | 1.09 | -0.05 | -4.39% | 1.14 | 1.15 | 1.05 |
| Apr 15, 2025 | 1.16 | -0.04 | -3.33% | 1.20 | 1.23 | 1.09 |
| Apr 14, 2025 | 1.22 | -0.06 | -4.69% | 1.28 | 1.28 | 1.16 |
| Apr 11, 2025 | 1.21 | 0.11 | 10.00% | 1.10 | 1.22 | 1.09 |
| Apr 10, 2025 | 1.12 | -0.05 | -4.27% | 1.17 | 1.18 | 1.07 |
| Apr 9, 2025 | 1.20 | 0.18 | 17.65% | 1.02 | 1.30 | 1.01 |
| Apr 8, 2025 | 1.02 | -0.19 | -15.70% | 1.21 | 1.21 | 1.00 |
| Apr 7, 2025 | 1.14 | 0.04 | 3.64% | 1.10 | 1.16 | 0.98 |
| Apr 4, 2025 | 1.14 | -0.03 | -2.56% | 1.17 | 1.17 | 1.05 |
| Apr 3, 2025 | 1.20 | -0.10 | -7.69% | 1.30 | 1.32 | 1.20 |
| Apr 2, 2025 | 1.33 | -0.01 | -0.75% | 1.34 | 1.39 | 1.32 |
| Apr 1, 2025 | 1.32 | -0.07 | -5.04% | 1.39 | 1.45 | 1.31 |
| Mar 31, 2025 | 1.38 | 0.02 | 1.47% | 1.36 | 1.40 | 1.30 |
| Mar 28, 2025 | 1.40 | -0.05 | -3.45% | 1.45 | 1.45 | 1.36 |
| Mar 27, 2025 | 1.46 | 0.06 | 4.29% | 1.40 | 1.49 | 1.40 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Akoya Biosciences, Inc. Company profile
About Akoya Biosciences Inc
Akoya Biosciences, Inc. is a life sciences technology company. The Company deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. It offers contract research services laboratory, which is called as advanced biopharma solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Akoya Biosciences Inc revenues increased 29% to $54.9M. Net loss applicable to common stockholders increased from $21.8M to $44.4M. Revenues reflect Consumables segment increase of 68% to $14.3M, Instruments segment increase of 21% to $28.7M, North America segment increase of 39% to $28M, EMEA segment increase of 21% to $14.4M. Higher net loss reflects Selling.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
100 Campus Drive
6th Floor
MARLBOROUGH
MASSACHUSETTS 01762
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com